Susan Hasty, Publisher
Table of Contents . . . February 19th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
AIDS Therapies - Guidelines Updated for Adults and Adolescents
AIDS Therapies - Monoclonal Antibodies May Effectively Inhibit HIV
AIDS Therapies - HIV Mutants Show Resistance to Antiretroviral Treatment
AIDS Therapies - Once-Daily Protease Inhibitor Shows Fewer Side Effects
Pathogenesis - Gag/Gag-Pol Ratio Crucial for Viral Infectivity
AIDS Therapies - Data Presented on Substitution of Efavirenz for Protease Inhibitor
AIDS Therapies - HIV Population Shifts Following Highly Active Antiretroviral Therapy
AIDS Therapies - Nevirapine Can Be Safe, Effective for Salvage Treatment
AIDS Therapies - Survey Indicates Physicians' Preference for Single Protease Inhibitor
Disease Resistance - Peptide's Protective Mechanism Against HIV Revealed
HIV Screening - Testing Pregnant Women is Cost-Effective
Hyperemia - HIV Patients Display Reduced Vascular Reactivity
Immunology - (beta)-Chemokines Appear to Inhibit Bone Marrow Infection
Meningitis - Symptoms Differ in HIV Patients
Pathogenesis - Model Allows Evaluation of Nef Protein
Pathogenesis - Protein Plays Dual Role in Apoptosis Responses
Pathogenesis - T Lymphocytes Have Little Effect on Infection
Quality of Care - Inner City HIV Patients Do Not Receive Specialized Care
Sexually Transmitted Disease - One in Five Patients Denied Urgent Access to Sexual Health Clinics
TT Virus - Parental Exposure, HIV, Keep Viral Persistence High in Italy
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.